oligomerix.com
Get leads like Oligomerix — and thousands more
Build targeted lists by tech stack, traffic, and more
Oligomerix: The Stealth Biotech Targeting Tau
A tiny team with a massive mission: stop neurodegenerative disease at the molecular level.
In the brutal world of biotech, where billion-dollar R&D budgets are the norm, Oligomerix is playing a different game. With just 16 employees and a laser focus on tauopathies—diseases like Alzheimer's and PSP—they are betting that precision beats scale.
"They aren't trying to cure everything; they are trying to cure the one thing that kills the brain's connectivity."
The Tau Hypothesis
While the rest of the industry chases amyloid plaques in Alzheimer's—often with mixed results—Oligomerix targets the 'other' villain: tau protein aggregation. Their proprietary small molecules inhibit the aggregation of tau, potentially offering a disease-modifying therapy. This isn't just incremental science; it's a strategic pivot to a mechanism many believe is the true driver of cognitive decline.
The Leadership
The team is lean but credentialed. CEO James Moe brings strategic depth, while CSO Eliot Davidowitz anchors the science. With a C-suite that includes finance (Robert Foerster) and commercial ops (Jack Pasini), Oligomerix is structured like a company preparing for a pivot from discovery to development. They are small enough to move fast, yet experienced enough to navigate the FDA gauntlet.
The digital footprint reveals a company in stealth mode. Their website generates less than 1,000 visits a month, with 42% of traffic being direct—meaning insiders, investors, or partners typing the URL directly. The lack of backlinks and the reliance on a single branded keyword ('william earhardt md') suggests a deliberate silence. They aren't marketing to the public; they are networking with the right people.
- Niche Focus: Specialized in tauopathies (Alzheimer's, PSP, FTD) rather than broad neurodegeneration.
- Asset-Light Model: Operating with $2.5M revenue and likely minimal burn rate pre-clinical trials.
- Tech Stack: Built on modern frameworks (Tailwind, Bootstrap) but stripped down for utility, not flash.
The Sleeper Pick?
In a sector obsessed with hype, Oligomerix’s silence might be their loudest asset.
What tech stack does Oligomerix use?
How much traffic does Oligomerix get?
Traffic & Engagement
Traffic Sources
Where is Oligomerix's audience located?
What keywords does Oligomerix rank for?
1 keywordsHow is Oligomerix's SEO?
Meta Tags
Oligomerix - Disease‐Modifying Therapy, Tauopathies Treatment
Oligomerix is a biotechnology company focused on developing disease-modifying and treatment therapeutics for neurodegenerative diseases
H1 Tags
Schema Types
What is Oligomerix's revenue?
Who works at Oligomerix?
Loading leads...
What do customers think of Oligomerix?
No Trustpilot reviews available for this company.
Frequently Asked Questions about Oligomerix
What is Oligomerix's Revenue?
What does Oligomerix do?
How fast is Oligomerix growing?
What technologies does Oligomerix use?
Who are Oligomerix's competitors?
Export Data
Unlock all exports
Download CSVs, JSONs & full reports
How to contact Oligomerix?
Social Profiles
Contact Information
Export oligomerix.com Data
Download the complete tech stack, analytics, leads, and company data for oligomerix.com in JSON or CSV format. Use it for your sales pipeline, competitive analysis, or research.
Raw JSON Data
Click "Show" to view the raw API response data
About oligomerix.com
Oligomerix is a biotechnology company focused on developing disease-modifying and treatment therapeutics for neurodegenerative diseases
Company Overview
oligomerix.com Social Media
Contact oligomerix.com
Email Addresses
Phone Numbers
Technology Stack
oligomerix.com uses 15 technologies across their website including Font Awesome, Google Fonts, HSTS, PHP, and more.
Fonts
Font Awesome, Google Fonts
Security
HSTS
Programming Languages
PHP
CMS
WordPress
Analytics & Marketing
Google Analytics
Performance
Lazy Loading, Priority Hints
Traffic & Audience
oligomerix.com receives approximately 906 monthly visitors and ranks #10,146,062 globally. The website has a bounce rate of 40% with visitors viewing an average of 1.1 pages per visit. Users spend an average of 0:00 on the site.
The majority of oligomerix.com's traffic comes from .
Frequently Asked Questions
What is oligomerix.com?
What technologies does oligomerix.com use?
How do I contact oligomerix.com?
What are oligomerix.com's social media accounts?
How popular is oligomerix.com?
Related Searches
This page provides publicly available information about oligomerix.com. Data is collected from various public sources and may not always be up to date. For the most accurate information, please visit oligomerix.com directly at https://oligomerix.com.